TaylorJSLangstonJW: Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis. Int J Radiat Oncol Biol Phys: 36, 1251–1261, 1996.
2.
DiChiroGOldfieldE: Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies. Am J Roentgenol: 150, 189–197, 1988.
3.
MineuraKSasajimaT: Perfusion and metabolism in predicting the survival of patients with cerebral gliomas. Cancer73: 2386–2394, 1994.
4.
ValkPEDillonWP. Radiation injury of the brain. Am J Neuroradiol12: 45–62, 1991.
5.
SchwartzRBCarvalhoPA: Radiation necrosis vs high grade recurrent glioma: differentiation by using dual isotope SPECT 201-Tl and Tc-HMPAO. AmJ Roentgenol158: 399–404, 1992.
6.
DerlonJMPetit-TabouéMC: The in vivo metabolic pattern of low-grade brain gliomas: a PET study using FDG and 11-C-L-methylmetionine. Neurosurgery40: 277–288, 1997.
7.
FischmanAJThortonAF: FDG hypermetabolism associated with inflammatory necrotic changes following radiation of meningioma. J Nucl Med38: 1027–1029, 1997.
8.
NelsonSJDayMR: Alignment of volume MR images and high resolution FDG PET images for the evaluation of patients with brain tumors. J Comput Assist Tomogr21: 183–191, 1997.
9.
BuchpingelCAAlaviJB: Comparison of PET-FDG and SPECT 201-Tl in distinguishing radiation necrosis from tumor recurrence in the brain. J Nucl Med38: 90622P., 1997.
10.
MaldonadoACalvoF: A-portación de la PET-FDG al diagnóstico diferencial recidiva vs radionecrosis en tumores cerebrales. OncologíaPS1-68: 104P., 1997.
